Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis CA Randomized Open-Label Study of Pegylated Interferon-α-2a versus Pegylated Interferon-α-2b

被引:0
|
作者
Gaetano Scotto
Vincenzina Fazio
Chiara Fornabaio
Alessandra Tartaglia
Rocco Di Tullio
Annalisa Saracino
Gioacchino Angarano
机构
[1] University of Foggia,Clinic of Infectious Diseases
[2] Hospital of Foggia,Clinical Chemistry Laboratory
来源
Drugs | 2008年 / 68卷
关键词
Viral Load; Sustained Virological Response; Early Virological Response; Viral Kinetic; Standard Interferon;
D O I
暂无
中图分类号
学科分类号
摘要
Objectives: The purpose of this randomized open-label study was to assess the efficacy of treatment with pegylated interferon-α-2a versus pegylated interferon-α-2b, both plus ribavirin, in inducing early and sustained virological response (EVR and SVR) in chronic hepatitis C non-responders.
引用
收藏
页码:791 / 801
页数:10
相关论文
共 50 条
  • [31] Effects of pegylated interferon-α-2a monotherapy on growth in Japanese children with chronic hepatitis C
    Tsunoda, Tomoyuki
    Inui, Ayano
    Kawamoto, Manari
    Sogo, Tsuyoshi
    Komatsu, Haruki
    Fujisawa, Tomoo
    HEPATOLOGY RESEARCH, 2014, 44 (03) : 251 - 258
  • [32] A randomized, controlled trial of combination therapy for chronic hepatitis B:: Comparing pegylated interferon-α2b and lamivudine with lamivudine alone
    Chan, HLY
    Leung, NWY
    Hui, AY
    Wong, VWS
    Liew, CT
    Chim, AML
    Chan, FKL
    Hung, LCT
    Lee, YT
    Tam, JSL
    Lam, CWK
    Sung, JJY
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) : 240 - 250
  • [33] Administration of pegylated interferon-α-2a or -2b does not induce sickness behavior in Lewis rats
    Loftis, Jennifer M.
    Wall, Jennifer M.
    Pagel, Rebecca L.
    Hauser, Peter
    PSYCHONEUROENDOCRINOLOGY, 2006, 31 (10) : 1289 - 1294
  • [34] Generalized flare of pustular psoriasis induced by PEGylated interferon-α2b therapy for chronic hepatitis C
    Wu, Meng-Chi
    Lee, J. Yu-Yun
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 (04) : E69 - E72
  • [35] Bilateral Skin Ulceration after Injection of Pegylated Interferon-α-2b in a Patient with Chronic Hepatitis C
    L. Gallelli
    V. Guadagnino
    B. Caroleo
    N. Marigliano
    G. B. De Sarro
    A. Izzi
    Clinical Drug Investigation, 2003, 23 : 615 - 619
  • [36] Bilateral skin ulceration after injection of pegylated interferon-α-2b in a patient with chronic hepatitis C
    Gallelli, L
    Guadagnino, V
    Caroleo, B
    Marigliano, N
    De Sarro, GB
    Izzi, A
    CLINICAL DRUG INVESTIGATION, 2003, 23 (09) : 615 - 619
  • [37] The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferon-α2b
    De Rosa, FG
    Bargiacchi, O
    Audagnotto, S
    Garazzino, S
    Cariti, G
    Veronese, L
    Raiteri, R
    Calleri, G
    Di Perri, G
    ANTIVIRAL THERAPY, 2006, 11 (02) : 165 - 171
  • [38] Pegylated interferon-α2a treatment of chronic SIV-infected macaques
    Asmuth, D. M.
    Abel, K.
    George, M. D.
    Dandekar, S.
    Pollard, R. B.
    Miller, C. J.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2008, 37 (01) : 26 - 30
  • [39] Randomized Trial Comparing Pegylated Interferon α-2b Versus Pegylated Interferon α-2a, Both Plus Ribavirin, to Treat Chronic Hepatitis C in Human Immunodeficiency Virus Patients
    Laguno, Montserrat
    Cifuentes, Carmen
    Murillas, Javier
    Veloso, Sergio
    Larrousse, Maria
    Payeras, Antoni
    Bonet, Lucia
    Vidal, Francesc
    Milinkovic, Ana
    Bassa, Antoni
    Villalonga, Concha
    Perez, Inaki
    Tural, Cristina
    Martinez-Rebollar, Maria
    Calvo, Marta
    Luis Blanco, Jose
    Martinez, Estaban
    Sanchez-Tapias, Jose M.
    Gatell, Jose M.
    Mallolas, Jose
    HEPATOLOGY, 2009, 49 (01) : 22 - 31
  • [40] Modelling of early viral kinetics and pegylated interferon-α2b pharmacokinetics in patients with HBeAg-positive chronic hepatitis B
    ter Borg, Martijn J.
    Hansen, Bettina E.
    Herrmann, Eva
    Zeuzem, Stefan
    Cakaloglu, Yilmaz
    Karayalcin, Selim
    Flisiak, Robert
    van 't Veen, Annemarie
    de Man, Robert A.
    Schalm, Solko W.
    Janssen, Harry L. A.
    Haagmans, Bart L.
    ANTIVIRAL THERAPY, 2007, 12 (08) : 1285 - 1294